Abeona Therapeutics (ABEO) Other Non-Current Assets (2010 - 2026)
Abeona Therapeutics' (ABEO) quarterly Other Non-Current Assets came in at $827000.0 in Q1 2026, up 1350.88% year-on-year from $57000.0 in Q1 2025, and up 5.89% quarter-over-quarter from $781000.0 in Q4 2025.
Abeona Therapeutics (ABEO) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $827000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 1350.88% year-over-year to $827000.0 in Q1 2026; TTM through Mar 2026 was $827000.0, a 1350.88% increase from a year earlier, with the FY2025 full-year figure at $781000.0, up 713.54% from the prior year.
- Other Non-Current Assets climbed to $827000.0 in Q1 2026 per ABEO's latest filing, from $781000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.3 million in Q3 2022 and bottomed at $20000.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $338000.0 (2022), against an average of $573588.2.
- Across the five-year window, Other Non-Current Assets slumped 98.27% in 2022 and jumped 1350.88% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $338000.0 in 2022, then declined by 18.05% to $277000.0 in 2023, then slumped by 65.34% to $96000.0 in 2024, then soared by 713.54% to $781000.0 in 2025, then increased by 5.89% to $827000.0 in 2026.
- Per Business Quant, the three latest ABEO Other Non-Current Assets figures stand at $827000.0 (Q1 2026), $781000.0 (Q4 2025), and $338000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | 827,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 827,000.00 |
| Dec 31, 2025 | 781,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 338,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 338,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 338,000.00 |
| Dec 31, 2023 | 277,000.00 |
| Sep 30, 2023 | 338,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 338,000.00 |
| Sep 30, 2022 | 5.34 Mn |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 5.89 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Jun 30, 2021 | 1.16 Mn |